Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Regulation, FDA Oncology

Paul G. Kluetz

MD

🏢US Food and Drug Administration🌐USA

Deputy Director, Oncology Center of Excellence

45
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Paul Kluetz leads FDA efforts on patient-focused drug development and is a driving force behind Project Patient Voice and integration of patient experience data into oncology review. His work has shaped PRO guidance and the use of symptom and tolerability endpoints in cancer trials. He has advanced patient-centered regulatory methodology.

Share:

🧪Research Fields 研究领域

oncology regulation
patient reported outcomes
FDA PRO guidance
Project Patient Voice
regulatory science

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Paul G. Kluetz 的研究动态

Follow Paul G. Kluetz's research updates

留下邮箱,当我们发布与 Paul G. Kluetz(US Food and Drug Administration)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment